584 related articles for article (PubMed ID: 19608019)
21. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
22. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
23. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.
Gouni-Berthold I; Berthold HK; Chamberland JP; Krone W; Mantzoros CS
Clin Endocrinol (Oxf); 2008 Apr; 68(4):536-41. PubMed ID: 17973945
[TBL] [Abstract][Full Text] [Related]
24. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
Chitturi S; Farrell G; Frost L; Kriketos A; Lin R; Fung C; Liddle C; Samarasinghe D; George J
Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
[TBL] [Abstract][Full Text] [Related]
25. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
[TBL] [Abstract][Full Text] [Related]
27. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
28. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
29. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Ohata K; Hamasaki K; Toriyama K; Matsumoto K; Saeki A; Yanagi K; Abiru S; Nakagawa Y; Shigeno M; Miyazoe S; Ichikawa T; Ishikawa H; Nakao K; Eguchi K
Cancer; 2003 Jun; 97(12):3036-43. PubMed ID: 12784339
[TBL] [Abstract][Full Text] [Related]
30. The evolving role of leptin and adiponectin in chronic liver diseases.
Tsochatzis E; Papatheodoridis GV; Archimandritis AJ
Am J Gastroenterol; 2006 Nov; 101(11):2629-40. PubMed ID: 16952281
[TBL] [Abstract][Full Text] [Related]
31. The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum.
Seidel N; Volkmann X; Länger F; Flemming P; Manns MP; Schulze-Osthoff K; Bantel H
Hepatology; 2005 Jul; 42(1):113-20. PubMed ID: 15920717
[TBL] [Abstract][Full Text] [Related]
32. Hepatic steatosis in Iranian patients with chronic hepatitis C.
Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
[TBL] [Abstract][Full Text] [Related]
33. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
[TBL] [Abstract][Full Text] [Related]
34. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):789-94. PubMed ID: 17700265
[TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
36. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
Aksu HS; Kurtaran B; Onlen Y; Namiduru M; Inkaya AC; Kandemir O; Doran F; Evirgen O; Alpay Y; Tekin SK; Kurekci Y; Unlu B; Midikli D; Taşova Y; Ozdener F; Erdogan S
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
[TBL] [Abstract][Full Text] [Related]
37. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
Pravdova E; Macho L; Fickova M
Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
[TBL] [Abstract][Full Text] [Related]
38. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
39. Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.
Baranova A; Jarrar MH; Stepanova M; Johnson A; Rafiq N; Gramlich T; Chandhoke V; Younossi ZM
Digestion; 2011; 83(1-2):32-40. PubMed ID: 20847561
[TBL] [Abstract][Full Text] [Related]
40. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
